SCI Pharmtech Inc (4119.TW) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · Taiwan · ISIN TW0004119003
SCI Pharmtech Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.52 bn TWD | 1.34 bn TWD |
| Gross profit | 410.67 m TWD | 319.47 m TWD |
| Operating income | 198.29 m TWD | 155.25 m TWD |
| EBIT | 676.13 m TWD | 155.25 m TWD |
| Net income | 534.68 m TWD | 107.37 m TWD |
| Diluted EPS – continuing operations | 4.46 TWD | 0.90 TWD |
Full history since 2002, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SCI Pharmtech Inc
SCI Pharmtech, Inc. engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals. The company offers active pharmaceutical ingredients, including adenine, articaine HCl, atomoxetine HCl, bisoprolol hemifumarate, brinzolamide, buprenorphine and buprenorphine HCl, cannabidol, divalproex sodium, duloxetine HCl, hydroxychloroquine sulfate, loxoprofen sodium, methylphenidate HCl, pentobarbital sodium, pimobendan, probucol, propafenone HCI, sodium valproate, thiopental, and valproic acid; and develops benserazide, CBN, and CBDv. It also provides intermediate products, such as diethyl isobutyl malonate, benzhydrylamine, 1-Benzhydrylazetidin-3-ol, azetidin-3-ol hydrogenchloride, 1-(2-hydroxyphenyl)-3-phenylpropan-1-one, ritalinic acid, d-ritalinic acid HCl, pyrogallol aldehyde, menthadienol, 5-pentylbenzene-1,3-diol olivetol, methyl 2,4-dihydroxy-6-pentylbenzoate, ethyl 2,4-dihydroxy-6-pentylbenzoate ethyl olivetolate, divarinol, lisdexamfetamine intermediate, UDP-GIcNAz, and UDP-GaINAz. In addition, the company offers customized production services. It operates in Italy, Spain, the Netherlands, Belgium, the United States, Japan, Germany, Taiwan, Switzerland, and internationally. SCI Pharmtech, Inc. was incorporated in 1987 and is based in Taoyuan City, Taiwan.
More stocks
- Sol Gel Technologies Ltd (SLGL)
- Archer Limited (ARCH.OL)
- Olympia Financial Group Inc (OLY.TO)
- Silver Bow Mining Corp. (SBMT)
- Premia S.A. (PREMIA.AT)
- Staude Capital Global Value Fund Ltd (GVF.AX)
- Kjell Group AB (KJELL.ST)
- Inversiones Doalca SOCIMI SA (YDOA.MC)
- Shandong Longertek Technology Co Ltd (300594.SZ)
- SHOULDER INNOVATIONS, INC. (SI)
- Kao Hsiung Chang Iron & Steel Corp (2008.TW)
- InflaRx N.V. (IFRX)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.